A. Wieczorek

Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans.

A. Wieczorek, Claudio Rhyner, L H Block · Proceedings of the National Academy of Sciences · 1985 · 95 citations · Full text

Life Sciences, Biochemistry, Oncology +10

EXP3174, a metabolite of losartan (MK954, DuP753) is more potent than losartan in blocking the angiotensin ll-induced responses in vascular smooth muscle cells

Agapios Sachinidis, Yon Ko, Maria-Katharina Meyer zu BricBkwedde et al. · Journal of Hypertension · 1993 · 53 citations

Medicine, Pharmacology, Cell Signaling +10

Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: first clinical evaluation of a novel tumor marker.

A. Wieczorek, V. Sitaramam, Werner Machleidt et al. · PubMed · 1987 · 45 citations

Medicine, Biochemistry, Oncology +15

Synergistic Action of Angiotensin II, Insulin- Like Growth Factor-I, and Transforming Growth Factor-β on Platelet-Derived Growth Factor-BB, Basic Fibroblastic Growth Factor, and Epidermal Growth Factor-Induced DNA Synthesis in Vascular Smooth Muscle Cells

Yon Ko, Heike Stiebler, Georg Nickenig et al. · American Journal of Hypertension · 1993 · 30 citations

Life Sciences, Cell Biology, Molecular Biology +9

Lipoproteins Induce Expression of the Early Growth Response Gene-1 in Vascular Smooth Muscle Cells from Rat

Agapios Sachinidis, Y. Ko, A. Wieczorek et al. · Biochemical and Biophysical Research Communications · 1993 · 28 citations

Life Sciences, Cell Biology, Molecular Biology +8